Michael Heffernan is the Founder and Chairman of the Board of Collegium Pharmaceutical. Mr. Heffernan served as President and Chief Executive Officer (CEO) of Collegium Pharmaceutical until June 2018. He is a successful entrepreneur and biopharmaceutical leader with over 25 years of experience building and leading development stage and commercial companies.
Mr. Heffernan co-founded Avenge Bio, an Immuno-Oncology company that he is actively managing. He was previously CEO of Onset Dermatologics, a dermatology company that he founded and spun out of Collegium to create PreCision Dermatology and was later sold to Valeant. Mr. Heffernan held previous positions as co-founder and CEO of Clinical Studies Ltd., a pharmaceutical contract research organization that was sold to PhyMatrix Corp, a public healthcare services company, and later served as CEO and Chairman of PhyMatrix Corp. Mr. Heffernan began his career at Eli Lilly and Company and served in numerous sales and marketing roles. He has also been an advisor, investor and board member in a number of biopharma, medical device and healthcare services companies. Mr. Heffernan serves on the board of directors of Akebia Therapeutics, Inc. (AKBA), Trevi Therapeutics, Inc. (TRVI), Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and Synlogic, Inc. (SYBX). Mr. Heffernan previously served on the board of directors of Keryx Biopharmaceuticals, Inc., a public pharmaceutical company prior to its merger with Akebia, Ocata Therapeutics, Inc. (OCAT), Cornerstone Therapeutics Inc. (now known as Chiesi USA, Inc.) (CRTX), and Veloxis Pharmaceuticals A/S, prior to its acquisition by Asahi Kasei. Mr. Heffernan is a current member of the boards of several privately held companies. Mr. Heffernan earned his B.S. Degree in Pharmacy from the University of Connecticut.
What is Michael Thomas Heffernan's net worth?
The estimated net worth of Michael Thomas Heffernan is at least $839,569.08 as of December 22nd, 2022. Mr. Heffernan owns 28,023 shares of Collegium Pharmaceutical stock worth more than $839,569 as of November 23rd. This net worth approximation does not reflect any other investments that Mr. Heffernan may own. Additionally, Mr. Heffernan receives an annual salary of $110,000.00 as Director at Collegium Pharmaceutical. Learn More about Michael Thomas Heffernan's net worth.
How old is Michael Thomas Heffernan?
Mr. Heffernan is currently 60 years old. There are 5 older executives and no younger executives at Collegium Pharmaceutical. The oldest executive at Collegium Pharmaceutical is Dr. Thomas B. Smith FAAFP, M.D., Executive VP & Chief Medical Officer, who is 63 years old. Learn More on Michael Thomas Heffernan's age.
What is Michael Thomas Heffernan's salary?
As the Director of Collegium Pharmaceutical, Inc., Mr. Heffernan earns $110,000.00 per year. There are 5 executives that earn more than Mr. Heffernan. The highest earning executive at Collegium Pharmaceutical is Mr. Joseph J. Ciaffoni, President, CEO & Director, who commands a salary of $1,690,000.00 per year. Learn More on Michael Thomas Heffernan's salary.
How do I contact Michael Thomas Heffernan?
Has Michael Thomas Heffernan been buying or selling shares of Collegium Pharmaceutical?
Michael Thomas Heffernan has not been actively trading shares of Collegium Pharmaceutical over the course of the past ninety days. Most recently, Michael Thomas Heffernan sold 19,815 shares of the business's stock in a transaction on Tuesday, December 27th. The shares were sold at an average price of $23.73, for a transaction totalling $470,209.95. Following the completion of the sale, the director now directly owns 28,023 shares of the company's stock, valued at $664,985.79. Learn More on Michael Thomas Heffernan's trading history.
Who are Collegium Pharmaceutical's active insiders?
Are insiders buying or selling shares of Collegium Pharmaceutical?
During the last year, insiders at the specialty pharmaceutical company sold shares 9 times. They sold a total of 202,376 shares worth more than $6,618,056.46. The most recent insider tranaction occured on September, 13th when EVP Thomas B Smith sold 9,593 shares worth more than $351,295.66. Insiders at Collegium Pharmaceutical own 4.0% of the company.
Learn More about insider trades at Collegium Pharmaceutical. Information on this page was last updated on 9/13/2024.
